Characteristics | Patient No. 1 | Patient No. 2 |
---|---|---|
Male | Male | |
73 | 81 | |
Former-smoker | Former-smoker | |
72% | 70% | |
2800 ml (93%) | 3110 ml (121%) | |
3900 ml (94%) | 4570 ml (122%) | |
57% | 47% | |
Squamous cell carcinoma | Squamous cell carcinoma | |
IIIA | IA | |
Left lower lobe | Left lower lobe | |
Lobectomy | Lobectomy | |
Chemotherapy and radiotherapy | No | |
54 days after finishing radiotherapy | 14 days after surgical resection |
Characteristics | N = 13 (%) | |
---|---|---|
Male | 11 (84.6) | |
Female | 2 (15.4) | |
73.3 ± 4 | ||
Current smoker | 3 (23.1) | |
Former-smoker | 8 (61.5) | |
Never-smoker | 2 (15.4) | |
0.71 ± 0.08 | ||
ml % | 2769 ± 690 101.6 ± 20 | |
ml % | 3910 ± 818 105 ±19 | |
% | 74.2 ±21 | |
Squamous cell carcinoma | 7 (53.8) | |
Adenocarcinoma | 5 (38.5) | |
Adenosquamous cell carcinoma | 1 (7.7) | |
pT1a | 3 (23.0) | |
pT2a | 6 (46.2) | |
pT2b | 4 (30.8) | |
IA | 2 (15.4) | |
IB | 2 (15.4) | |
IIA | 3 (23.0) | |
IIB | 4 (30.8) | |
IIIA | 2 (15.4) | |
Left lower lobe | 7 (53.8) | |
Right lower lobe | 4 (30.8) | |
Right middle lobe | 2 (15.4) | |
Lobectomy Bilobectomy | 11 (84.6) 2 (15.4) | |
Adjuvant chemotherapy | 4 (30.8) | |
Adjuvant radiotherapy | 1 (7.7) |